“I’m not trying to prove anything, by the way. I’m a scientist and I know what constitutes proof.
But the reason I call myself by my childhood name is to remind myself that a scientist must also be absolutely like a child. If he sees a thing, he must say that he sees it, whether it was what he thought he was going to see or not.
See first, think later, then test. But always see first. Otherwise you will only see what you were expecting.”
Our 5 last publications
To see all of them click here
Contribution of capillary zone electrophoresis hyphenated with drift tube ion mobility mass spectrometry as complementary tool to microfluidic reversed phase liquid chromatography for antigen discovery.Gou MJ, Kose MC, Crommen J, Nix C, Cobraiville G, Coers J, Fillet M Int. J. Mol. Sci. 2022 Nov 1; 23(21):13350.
Validation of an LC-MS/MS method using solid-phase extraction for the quantification of 1-84 parathyroid hormone: Towards a candidate reference measurement procedure.Farré-Segura J, Le Goff C, Lukas P, Cobraiville G, Fillet M, Servais AC, Delanaye P, Cavalier E Ciln. Chem. 2022 Nov 3; 68(11):1399-1409.
Overview on microfluidics devices for monitoring brain disorder biomarkers.Nix C, Ghassemi M, Crommen J, Fillet M TrAC 2022 Oct; 155:116693.
In vitro/in vivo degradation analysis of trastuzumab by combining specific capture on HER2 mimotope peptide modified material and LC-QTOF-MS.Lu L, Liu X, Zuo C, Zhou J, Zhang A, Fillet M, Crommen J, Jiang Z, Wang Q Anal. Chim. Acta 2022 Sep 8; 1225:340199.
Qualitative and quantitative comparison of different commercially available 1-84 parathyroid hormone proteins to the WHO international standard 95/646 using orthogonal methods.Nyssen L, Fillet M, Cavalier E, Servais AC J. Pharm. Biomed. Anal. 2022 Sep 20; 219:114942.